Creative Life Science Unveils PIC/S GMP-Compliant Cell Therapy Platform at BIO Asia-Taiwan 2026, Bolstered by New Taiwan Regenerative Medicine Laws
PR Newswire Taiwan Overview According to PR Newswire, Creative Life Science is showcasing its PIC/S GMP-compliant cell therapy materials and manufacturing platform at BIO Asia-Taiwan 2026. The company's Zhubei biomanufacturing facility s...
